FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib ; volume:36 ; number:1 ; day:9 ; month:1 ; year:2017 ; pages:1-10 ; date:12.2017
Journal of experimental & clinical cancer research ; 36, Heft 1 (9.1.2017), 1-10, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Gao, Lixia
- Beteiligte Personen und Organisationen
-
Wang, Xuli
Tang, Yaoliang
Huang, Shuang
Hu, Chien-An Andy
Teng, Yong
SpringerLink (Online service)
- DOI
-
10.1186/s13046-016-0478-9
- URN
-
urn:nbn:de:1111-201702087776
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 09:00 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gao, Lixia
- Wang, Xuli
- Tang, Yaoliang
- Huang, Shuang
- Hu, Chien-An Andy
- Teng, Yong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
OXTR-mediated signaling in astrocytes contributes to anxiolysis
USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib
Sorafenib resistance of hepatocellular carcinoma : antibiotics second-line to Sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth resumption
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
OXTR-mediated signaling in astrocytes contributes to anxiolysis
USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib
Sorafenib resistance of hepatocellular carcinoma : antibiotics second-line to Sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth resumption
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
OXTR-mediated signaling in astrocytes contributes to anxiolysis
USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib
Sorafenib resistance of hepatocellular carcinoma : antibiotics second-line to Sorafenib therapy inhibit mitochondrial biogenesis and prevent tumor growth resumption